{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:14:28Z","timestamp":1762254868358,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s15010-024-02269-y","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T15:10:00Z","timestamp":1714576200000},"page":"1585-1593","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Use of oxazolidinones (linezolid or tedizolid) for the treatment of breast infections. A case series from a tertiary referral hospital"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9035-1450","authenticated-orcid":false,"given":"Cristina","family":"Kirkegaard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8023-3979","authenticated-orcid":false,"given":"Carlos Javier","family":"Parram\u00f3n-Teixid\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6771-6749","authenticated-orcid":false,"given":"Clara","family":"Morales-Comas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6272-6438","authenticated-orcid":false,"given":"Susana","family":"Clemente Bautista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3126-2623","authenticated-orcid":false,"given":"Joaqu\u00edn","family":"Rivero Deniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2115-344X","authenticated-orcid":false,"given":"Nuria","family":"Fern\u00e1ndez-Hidalgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,1]]},"reference":[{"key":"2269_CR1","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10911-011-9234-0","volume":"16","author":"GA Contreras","year":"2011","unstructured":"Contreras GA, Rodriguez JM. Mastitis: comparative etiology and epidemiology. J Mammary Gland Biol Neoplasia. 2011;16:339\u201356. https:\/\/doi.org\/10.1007\/s10911-011-9234-0.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"2269_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1746-4358-3-6","volume":"3","author":"LJ Kvist","year":"2008","unstructured":"Kvist LJ, Larsson BW, Hall-Lord ML, Steen A, Schalen C. The role of bacteria in lactational mastitis and some considerations of the use of antibiotic treatment. Int Breastfeed J. 2008;3:6. https:\/\/doi.org\/10.1186\/1746-4358-3-6.","journal-title":"Int Breastfeed J"},{"key":"2269_CR3","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1001\/jama.2023.0004","volume":"329","author":"AF Louis-Jacques","year":"2023","unstructured":"Louis-Jacques AF, Berwick M, Mitchell KB. Risk factors, symptoms, and treatment of lactational mastitis. JAMA. 2023;329:588\u20139. https:\/\/doi.org\/10.1001\/jama.2023.0004.","journal-title":"JAMA"},{"key":"2269_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/QCO.0000000000000529","volume":"32","author":"E Righi","year":"2019","unstructured":"Righi E, Carnelutti A, Bassetti M. Current role of oxazolidinones and lipoglycopeptides in skin and soft tissue infections. Curr Opin Infect Dis. 2019;32:123\u20139. https:\/\/doi.org\/10.1097\/QCO.0000000000000529.","journal-title":"Curr Opin Infect Dis"},{"key":"2269_CR5","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1128\/JCM.03395-15","volume":"54","author":"MP Crotty","year":"2016","unstructured":"Crotty MP, Krekel T, Burnham CA, Ritchie DJ. New gram-positive agents: the next generation of oxazolidinones and lipoglycopeptides. J Clin Microbiol. 2016;54:2225\u201332. https:\/\/doi.org\/10.1128\/JCM.03395-15.","journal-title":"J Clin Microbiol"},{"key":"2269_CR6","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1177\/0890334414546045","volume":"30","author":"HE Rowe","year":"2014","unstructured":"Rowe HE, Felkins K, Cooper SD, Hale TW. Transfer of linezolid into breast milk. J Hum Lact. 2014;30:410\u20132. https:\/\/doi.org\/10.1177\/0890334414546045.","journal-title":"J Hum Lact"},{"key":"2269_CR7","unstructured":"Linezolid. BMNIoCHaHD-. Drugs and Lactation Database (LactMed\u00ae) [Internet]. 2020 [Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501700\/. Accessed 12 Dec 2023."},{"key":"2269_CR8","unstructured":"(FDA) UFaDA. SIVEXTRO 2019 [Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/205436s005lbl.pdf. Accessed 12 Dec 2023."},{"key":"2269_CR9","unstructured":"(FDA) UFaDA. ZYVOX 2013 [Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/021130s032,021131s026,021132s031lbl.pdf. Accessed 12 Dec 2023."},{"key":"2269_CR10","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1128\/AAC.44.12.3408-3413.2000","volume":"44","author":"DL Stevens","year":"2000","unstructured":"Stevens DL, Smith LG, Bruss JB, McConnell-Martin MA, Duvall SE, Todd WM, et al. Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother. 2000;44:3408\u201313. https:\/\/doi.org\/10.1128\/AAC.44.12.3408-3413.2000.","journal-title":"Antimicrob Agents Chemother"},{"key":"2269_CR11","doi-asserted-by":"publisher","first-page":"CD008056","DOI":"10.1002\/14651858.CD008056.pub3","volume":"2016","author":"J Yue","year":"2016","unstructured":"Yue J, Dong BR, Yang M, Chen X, Wu T, Liu GJ. Linezolid versus vancomycin for skin and soft tissue infections. Cochrane Database Syst Rev. 2016;2016:CD008056. https:\/\/doi.org\/10.1002\/14651858.CD008056.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"2269_CR12","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1345\/aph.1G728","volume":"40","author":"PS McKinnon","year":"2006","unstructured":"McKinnon PS, Sorensen SV, Liu LZ, Itani KM. Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections. Ann Pharmacother. 2006;40:1017\u201323. https:\/\/doi.org\/10.1345\/aph.1G728.","journal-title":"Ann Pharmacother"},{"key":"2269_CR13","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.2147\/TCRM.S109444","volume":"12","author":"JA Vazquez","year":"2016","unstructured":"Vazquez JA, Arnold AC, Swanson RN, Biswas P, Bassetti M. Safety of long-term use of linezolid: results of an open-label study. Ther Clin Risk Manag. 2016;12:1347\u201354. https:\/\/doi.org\/10.2147\/TCRM.S109444.","journal-title":"Ther Clin Risk Manag"},{"key":"2269_CR14","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02252-18","author":"X Lv","year":"2019","unstructured":"Lv X, Alder J, Li L, O\u2019Riordan W, Rybak MJ, Ye H, et al. Efficacy and safety of tedizolid phosphate versus linezolid in a randomized phase 3 trial in patients with acute bacterial skin and skin structure infection. Antimicrob Agents Chemother. 2019. https:\/\/doi.org\/10.1128\/AAC.02252-18.","journal-title":"Antimicrob Agents Chemother"},{"key":"2269_CR15","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00228-023-03500-9","volume":"79","author":"F Elbarbry","year":"2023","unstructured":"Elbarbry F, Moshirian N. Linezolid-associated serotonin toxicity: a systematic review. Eur J Clin Pharmacol. 2023;79:875\u201383. https:\/\/doi.org\/10.1007\/s00228-023-03500-9.","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-024-02269-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-024-02269-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-024-02269-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T18:51:00Z","timestamp":1722365460000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-024-02269-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,1]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["2269"],"URL":"https:\/\/doi.org\/10.1007\/s15010-024-02269-y","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"type":"print","value":"0300-8126"},{"type":"electronic","value":"1439-0973"}],"subject":[],"published":{"date-parts":[[2024,5,1]]},"assertion":[{"value":"24 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Vall d\u2019Hebron Research Institute Ethics Committee [registration code EOM(AG)030\/2023(6143)].","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Need for informed consent was waived, as data and samples were analysed retrospectively, and the study was non-interventional in nature.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}